Stocks
Arcturus Therapeutics Holdings (ARCT) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -70.6 | -201.7 | 13.7 | -75.1 | -24.2 | -59.3 | ||
| Changes by years, y/y, % | +189% | +185% | -107% | -648% | -68% | +2.8% | |||
Arcturus Therapeutics Holdings. EBITDA US GAAP, bln rub
Arcturus Therapeutics Holdings. EBITDA US GAAP, changes, %
Arcturus Therapeutics Holdings. EBITDA US GAAP, sum by quarters, bln rub
Arcturus Therapeutics Holdings (ARCT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -15.1 | -7.49 | -25.5 | -16.5 | -9.83 | -59.3 | |
| Changes by years, y/y, % | -112% | -106% | +35% | -68% | -32% | |||
| Changes by quarters, q/q, % | +4% | -51% | +241% | -36% | -40% | |||
